The American Medical Association (AMA) this week called for an end to direct-to-consumer advertising for prescription drugs and implantable medical devices, according to CBS News. The ads contribute to increasing costs, and lead to patient demand for inappropriate treatment, the group says.
“Today’s vote in support of an advertising ban reflects concerns among physicians about the negative impact of commercially driven promotions and the role that marketing costs play in fueling escalating drug prices,” AMA Board Member Dr. Patrice Harris said in a news release. “Direct-to-consumer advertising also inflates demand for new and more expensive drugs, even when these drugs may not be appropriate.”
Drug manufacturers spent $4.5 billion for ads in the last two years, a 30 percent increase, according to the AMA. Prices for prescription drugs rose almost 5 percent this year, the article notes.